Monocytes are among the major myeloid cells that respond to Toxoplasma, a ubiquitous foodborne 15 that infects ≥ 1 billion people worldwide, in human peripheral blood. As such, a molecular 16 understanding of human monocyte-Toxoplasma interactions can expedite the development of 17 novel human toxoplasmosis control strategies. Current molecular studies on monocyte-18 Toxoplasma interactions are based on average cell or parasite responses across bulk cell 19 populations. Although informative, population-level averages of monocyte responses to 20 Toxoplasma have sometimes produced contradictory results, such as whether CCL2 or IL12 define 21 effective monocyte response to the parasite. Here, we used single-cell dual RNA sequencing 22
(scDual-Seq) to comprehensively define, for the first time, the monocyte and parasite 23 transcriptional responses that underpin human monocyte-Toxoplasma encounters at the single cell 24 level. We report extreme transcriptional variability between individual monocytes. Furthermore, we 25 report that Toxoplasma-exposed and unexposed monocytes are transcriptionally distinguished by 26 a reactive subset of CD14 ++ CD16monocytes. Functional cytokine assays on sorted monocyte 27 populations show that the infection-distinguishing monocytes secrete high levels of chemokines, 28 such as CCL2 and CXCL5. These findings uncover the Toxoplasma-induced monocyte 29 transcriptional heterogeneity and shed new light on the cell populations that largely define cytokine 30 and chemokine secretion in human monocytes exposed to Toxoplasma.
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Keywords: Single-cell, RNA-seq, human monocytes, Toxoplasma INTRODUCTION 33 Majority of lethal human pathogens spend a significant portion of their life-cycle inside immune 34 cells, mostly monocytes and macrophages 1,2 . The intracellular lifestyle potentially enable these 35 pathogens to not only evade the host's immune surveillance but also antimicrobial therapy 2 . As 36 such, a molecular understanding of pathogen encounters with host immune cells has the potential 37 to identify novel therapeutic targets. Current knowledge on host-pathogen interactions is largely 38 based on experiments performed in bulk populations of host and/or pathogen cells. However, host-39 pathogen interaction is mostly a single cell problem involving dynamic host and pathogen gene 40 regulatory programs that often produce distinct outcomes in individual cells in a host. For example, 41 bacteria encounters with macrophages from the same individual can simultaneously produce 42 macrophages that; 1) are infected, while others remain uninfected, 2) kill the ingested bacteria, 43 while others support intracellular bacterial survival, and 3) undergo programmed cell death to 44 release the bacteria, while others survive and allow bacterial growth or persistence 3 . Similar 45 intraindividual heterogenous infection outcomes have been observed in vitro during viral 46 infections 4,5 and in vivo during active tuberculosis, during which sterilized and active lesions occur 47 simultaneously in the same host 6 . Phenotypically distinct variants of the same pathogen, such as 48 dormant and actively replicating Mycobacterium, have also been isolated from the same infected 49 host 7 . Although the molecular mechanisms underpinning these distinct intraindividual infection 50 outcomes are largely unknown, it is plausible that they impact disease pathogenesis and 51 antimicrobial therapy 8 . Thus, to understand the biology of infectious diseases and develop effective 52 control strategies, it is important to consider the overall outcome of an infection as a manifestation 53 of multiple distinct infection outcomes occurring simultaneous in individual cells within a host.
54
Toxoplasma gondii, the etiological agent for toxoplasmosis, is a zoonotic protozoan that infects 55 virtually all warm-blooded vertebrates 9 . In human peripheral blood, monocytes are among the 56 major myeloid cells that respond to the parasite by secreting interleukin 12 (IL12) 10 , which is 57 required to induce the production of the indispensable anti-Toxoplasma interferon-gamma (IFNγ) 58 cytokine 11 . Although usually studied in bulk host and/or parasite cells, when Toxoplasma interacts 59 with monocytes from the same individual, several possible outcomes can occur to produce distinct 60 monocyte and parasite subpopulations. The parasite can either enter the cell via active invasion to 61 reside within a non-fusogenic parasitophorous vacuole (PV) or be taken up via phagocytosis to 62 reside in a phagosome 10,12 . In certain cases, phagocytosed parasites can subsequently escape the 63 phagosome to establish a PV 13 . Although not infected, some monocytes can also be exposed to, 64 and manipulated by, secreted parasite factors through contact-dependent injection of parasite 65 molecules 14 . Some infected monocytes can undergo programmed cell death 15 thereby killing the 66 parasite within, while some uninfected bystander monocytes can be activated to produce high 67 levels of IL12 16 . There are multiple ways to achieve each of these infection outcomes, further 68 expanding the number of molecular pathways that may be regulating the outcome of monocyte- 
89
Here, we exploit the fact that both Toxoplasma and human mRNA are polyadenylated and can be 90 simultaneously profiled using standard scRNA-seq protocols to investigate the transcriptional 91 hallmarks of Toxoplasma interactions with monocytes from the same donor. We report significant 92 heterogeneity among individual monocytes and parasites. Furthermore, we find that Toxoplasma-93 exposed and control monocytes are transcriptionally distinguished by non-classical monocytes and 94 a novel subset of reactive classical monocytes.
95

RESULTS
96
Defining the single-cell transcriptome of Toxoplasma-exposed human monocytes
97
In this study, we used single-cell RNA sequencing (scRNA-seq; 10X Genomics) to perform 98 unbiased transcriptional analysis of human monocytes exposed to Toxoplasma for 1 hour. We 99 conducted several pre-processing steps (Materials and Methods) including quality control, 100 normalization, and scaling 25 to remove potential technical bias. The processed control (unexposed) 101 monocyte expression matrix contained 3,136 cells and 12,023 genes while the Toxoplasma-102 exposed monocyte data contained 1,352 cells and 10,795 genes. Unsupervised graph-based 103 clustering partitioned the unexposed monocytes into two clusters; hU1 (human-unexposed) and 104 hU2, which correspond to the non-classical (CD14 + CD16 ++ ) and classical (CD14 ++ CD16 -) 105 monocyte subsets, respectively 26 , (Figure 1A) . The Toxoplasma-exposed monocytes clustered 106 into three distinct groups: hE1 (human-exposed), which is composed entirely of non-classical 107 monocytes; hE2; and hE3, both of which were made mostly up of classical monocytes (Figure 1B) .
108
The proportions of classical and non-classical cells identified in both conditions (Figure 1A-B ) is 109 largely consistent with reports on the composition of circulating human monocytes 27 .
110
Next we used a Gini coefficient metric, a measure of population inequality ranging from zero 111 (complete equality) to one (complete inequality) to evaluate gene expression variability within the 112 monocyte subsets. Cells from the hE3 cluster showed significantly (FDR < 0.05, medium Gini 113 index = 0.93) higher Gini index relative to the other clusters ( Figure 1C) . In scRNA-seq mRNAs 114 from the parasite and the monocyte it infects are tagged with the same cell barcode, which enables 115 the reliable identification of Toxoplasma-exposed monocytes that are infected (contain parasite 116 mRNA) and uninfected (do not contain parasite RNA). Thus, to determine whether the differences 117 between monocyte clusters was due to differences in the number of infected monocytes, we 118 examined the proportion of infected cells in each of the Toxoplasma-exposed monocyte clusters.
119
There were no significant differences in the proportion of infected cells in each cluster (Figure 1D ).
120
However, it is worth noting that by injecting its effector proteins into host cells, Toxoplasma can 121 modulate the transcriptome of host cells without truly infecting them. As such, part of what we 122 consider exposed-uninfected (bystander) cells in this study may include cells that are injected with 123 parasite effector proteins or infected cells from which we were not able to recover parasite mRNA.
124
Nevertheless, when we restricted the unsupervised hierarchical clustering to the cells that contain, 125 or do not contain parasite mRNA, we did not observe new clustering patterns (not shown). Taken 126 together, we find that individual monocytes from the same donor respond variably to Toxoplasma 127 at the transcriptional level and that this transcriptional heterogeneity is more pronounced in the 128 classical monocyte (CD14+CD16-) subset.
129
CD16monocytes transcriptionally distinguish Toxoplasma-exposed and unexposed human 130 monocytes 131 Previous immunological and parasitological assays in human monocytes have reported differential 132 response to Toxoplasma between classical and non-classical monocyte subsets, as well as 133 between monocytes that are actively invaded and those that take up the parasites through 134 phagocytosis 10,28 . Having observed transcriptional heterogeneity in the Toxoplasma-exposed 135 monocytes, we determined whether a distinction between responsive and unresponsive monocyte 136 subsets can be discerned at the transcriptional level. A t-distributed stochastic neighbour 137 embedding (tSNE) plot, which depicts the similarity between cells based on their gene expression, 138 of the combined Toxoplasma-exposed and unexposed monocytes scRNA-seq data showed that 139 the exposed and control cells are clearly transcriptionally distinguished by the hE3 cluster ( Figure   140 2). As indicated above, although hE3 distinguished Toxoplasma-exposed and unexposed 141 monocytes, there was no evidence that cells in this cluster contained more parasite genes than the 142 hE1 or hE2 clusters.
143
To gain further insights into the Toxoplasma-exposed monocytes, we sub-divided cells in each 144 cluster into infected (contain parasite mRNA) and uninfected (no parasite mRNA) and preformed 145 differential expression (DE) analysis between the clusters. 711 genes were differentially expressed 146 (S1A), of which 418 were highly expressed in specific monocyte clusters ( Figure 3A) . 218 genes 147 were highly expressed in the hE3 cluster, of which 22 were highly expressed in the infected and 148 196 in both the infected and uninfected monocytes (Figure 3A and S1A) , suggesting that the 149 transcriptional heterogeneity in the hE3 cluster is driven by both the infected and uninfected 150 bystander cells. Interestingly, the number of human genes and reads were significantly lower (FDR 151 < 0.05) in hE3 infected and uninfected cells relative to other groups (Figure 3B) , without a 152 significant difference in the number of parasite genes. Similarly, out of the 80 highly expressed 153 genes in the hE1 cluster, 61 (76%) were expressed in both the infected and uninfected cells.
154
Despite being like the hE3 cluster in monocyte subset composition, the hE2 cluster had the least 155 number (16) of highly expressed DE genes.
156
To functionally annotate DE genes in hE1 or hE3 clusters, enrichment analysis was performed.
157
The top Gene Ontology terms enriched in DE genes that were highly expressed in both the 158 uninfected and infected cells in hE3 cluster included innate immune associated terms, such as 159 "immune effector process" (FDR = 3.48x10 -4 ), "myeloid cell activation involved in immune 160 response" (FDR = 4.10x10 -7 ), and "cell activation involved in immune response" (FDR = 2.95x10 -161 6 ) (S1B). Among the DE genes in the hE3 cluster were pro-inflammatory chemokines that are 162 known to be induced in human peripheral blood mononuclear cells and monocytes exposed to 182 Toxoplasma-exposed monocytes is reportedly initiated by the S100 calcium-binding protein A11 183 (S100A11) 17 . However, unlike the other members of the S100 family, including S100A4, 6 and 9 184 that were DE in hE1, S100A11 was not. Considering all DE genes, those highly expressed in hE1 185 included members of the MHC class 2 family and genes associated with interferon response (IFIT,
186
IRF and OAS gene families). Though few genes were DE solely in hE2, the cluster showed a high 187 expression of immune related genes that were also expressed in other groups, including CCL3,
188
CCL4, NFKBIA and IL1β. Certain DE genes expressed in hE3 and hE1 such as members of the 189 MHC class 1, cathepsins and proteasome complex, were not expressed in the hE2 cluster. In 190 summary we reveal an unprecedented level of transcriptional heterogeneity in Toxoplasma-191 exposed monocytes and that transcriptional response to the parasite at 1 h post exposure is 192 defined mostly by a subset CD16monocytes.
193
Monocyte response to Toxoplasma is defined by chemokine secretion
194
The observation that a subset of CD16monocyte subset (hE3) transcriptionally distinguish 195 Toxoplasma-exposed and unexposed monocytes prompted us to investigate whether the 196 transcriptional heterogeneity translate into a distinctive infection phenotype. To explore this, we 197 used monoclonal antibodies against the cell surface protein product of the CD98 gene that is highly 198 expressed in the hE3 cluster to sort Toxoplasma-exposed monocytes followed by functional 199 assays. We used a human multiplex cytokine array to measure the level of several cytokines and 200 chemokines, including CCL2 and IL12, in cell-free supernatants from the sorted CD98 + monocytes 201 ( Figure 4A) . CD98monocytes were used as controls. The sorted CD98 + cells secreted 202 significantly more CXCL5, CCL2 and MIP1, but less IL12 and IL6, compared to CD98monocytes 203 ( Figure 4B) . The level of IL1β, known to be secreted by monocytes in response to Toxoplasma 15 , 204 was induced in CD98 + . Therefore, Toxoplasma-induced transcriptional heterogeneity observed in 205 human monocytes can be linked to specific Toxoplasma-induced monocyte phenotypes at the 206 protein level.
207
Transcriptional heterogeneity of Toxoplasma exposed to monocytes 208 Host-pathogen encounters are highly dynamic processes modulated by both host-and pathogen-209 derived factors. Therefore, we investigated whether parasites display different transcriptional 210 profiles in individual monocytes. After data pre-processing and quality control we recovered 873 211 parasites, of which 299 shared cell barcodes with individual monocytes. In total, the 299 212 Toxoplasma cells expressed 2,556 genes. We initially grouped parasites based on the type of 213 monocyte they infected, however no DE genes were identified for any of these groups.
214
Subsequently, parasites were clustered into three distinct groups (hT1, hT2 and, hT3) based on 215 their gene expression ( Figure 5A) . Varying abundance of parasites were observed between 216 clusters, the largest being hT1 (585 parasites) and the smallest hT3 (109 parasites) ( Figure 5B & 217 C). However, in all cases approximately the same proportion, 33% to 37% of parasites were linked 218 to monocytes. To determine whether there were differences between infecting and bystander 219 parasites for a given cluster, the number of genes and reads were examined for each. Significant 220 differences were observed between infecting and bystander parasites of hT1 and hT2 (Figure 5D ).
221
However, on conducting DE analysis between the infecting and bystander parasites for each 222 cluster no DE genes were identified. To identify the genes that underpin the parasite transcriptional 223 heterogeneity in individual monocytes, we performed DE analysis between the parasite clusters. Of 224 the 169 DE genes 40, 73, and 80 were highly expressed in hT1, hT2 and hT3, respectively (S2A).
225
The top DE genes included several ribosomal proteins, the microneme protein 10 (MIC10), a 226 putative elongation factor 1-alpha (EF-1-ALPHA), and a dense granule protein (GRA12) in hT1; overnight prior to infection. The cells were left unexposed or exposed to freshly prepared parasites 254 at a multiplicity of infection (MOI) of 1:1, briefly centrifuged to bring the monocytes and parasite into 255 contact and incubated at 37 o C in 5% CO 2 for 1h before processing the cells for single-cell 256 sequencing or flow cytometry.
257
Single cell RNA-sequencing 258 Toxoplasma-exposed and unexposed monocytes from one donor were harvested and washed 259 three times in cold PBS supplemented with 0.1% bovine serum albumin (BSA, Thermo Fisher).
260
The scRNA-seq libraries were generated using the Chromium Single Cell 3 and 17 PCs in the unexposed and Toxoplasma-exposed monocytes, respectively. Clustering was 282 performed using the Smart local moving (SLM) algorithm 32 . To generate the tSNE plots of the combined exposed and unexposed monocytes data, the 18 significant PCs from the combined 284 dataset were used, which were based on the normalized and scaled expression matrix of all cells 285 filtered for each condition.
286
Toxoplasma cells were filtered based on a minimum expression of 30 genes, while genes 287 expressed in less than 3 cells were removed. Subsequently this data was normalized, scaled and 
312
Herein, we applied a combination of scRNA-seq and phenotyping of sorted cell populations to 313 provide a high dimensional insight into human monocyte-Toxoplasma interactions. We have shown 314 that individual monocytes from the same donor exhibit great transcriptional heterogeneity in 315 response to the parasite and that Toxoplasma-exposed and unexposed cells can be distinguished 316 transcriptionally by a subset of CD16monocytes, composed of both infected and potential 317 bystander cells. In addition, our results show that the transcriptional heterogeneity translates into 318 functional differences between individual monocyte clusters, including differences in CCL2 and 319 IL1β secretion, which previous studies have reported to be induced in human monocytes exposed 320 to either Toxoplasma or cell-free supernatant from Toxoplasma-infected cells 15,16 .
321
Previously, CD16 + monocytes were reported to distinguish responsive monocytes, based on IL12 322 secretion 9 . Here, although CD16+ cells can transcriptionally distinguish Toxoplasma-exposed and 323 unexposed monocytes, a clear distinction is only achieve with the by CD16subset. This 324 discrepancy may be due to several factors. Besides averaging responses in cell populations, which 325 can mask cell-to-cell differences in IL12 secretion, this and the previous study are based on 326 different phenotypes; transcript and protein abundance, which often do not match 32 . Importantly, 327 we investigated monocytes exposed to Toxoplasma for 1 hour, rather than 24 h as in the previous 328 study 9 . Thus, it is plausible that early (1 h) responses to the parasite are defined mostly by CD16 -329 monocytes while long-term (24 h) responses are modulated by CD16 + monocytes. As such 330 discrepancy between this and the previous study 9 could be temporal, rather than functional.
331
Nevertheless, we observed more IL12 in cell-free supernatants from control, compared to sorted 332 hE3 cells, suggesting that significant differences in IL12 secretion are discernible at 1 h post-333 infection. Noteworthy, primary human monocyte response to Toxoplasma was recently reported to 334 be defined more by the secretion of chemokines, including CCL2, than IL12 16 . Consistent with this 335 observation, we observed differential expression of several chemokines between the different 336 Toxoplasma-exposed monocyte clusters. Furthermore, sorted monocyte populations that 337 distinguish Toxoplasma-exposed and unexposed monocytes secreted more chemokines, including 338 CCL2 than the corresponding controls. We propose a future temporal scRNA-seq analysis of 339 monocyte-Toxoplasma encounters to determine whether additional monocyte clusters that 340 distinguish Toxoplasma-exposed and unexposed monocyte clusters emerge over time. phagocytic, and truly bystander monocyte subpopulations, which will greatly improve our current 356 analysis. Majority of genes that were differentially expressed in Toxoplasma-exposed relative to 357 unexposed monocytes were from uninfected cells. This may suggest that the responses in 358 bystander cells drive the phenotypic outcome of infection rather than transcriptional responses in 359 the parasites and monocytes they infect. However, as indicated above, since we identify infected 360 cells by the presence of parasite mRNA in it, it is possible that some of the exposed-uninfected 361 (considered bystander) monocytes are indeed infected, but we were not able to detect parasite 362 mRNA due to technical limitations or are truly uninfected but are injected with Toxoplasma effector 363 proteins. A more in-depth analysis will be possible once we transcriptionally define different 364 subpopulations of Toxoplasma-exposed monocytes, including actively invaded, phagocytic, and 365 exposed-uninfected subpopulations. 
